Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.22.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended
Mar. 31, 2022
Mar. 31, 2021
Total Net Revenue $ 2,150,705 $ 1,294,209
Total Cost of Sales 1,164,670 588,714
Gross Profit 986,035 705,495
Operating Expenses:    
Research and development 269,240 311,448
Selling, general and administrative 1,212,813 1,211,103
Depreciation and amortization 9,453 13,240
Total Operating Expenses 1,491,506 1,535,791
Operating Loss (505,471) (830,296)
Other Income (Expenses):    
Gain / (Loss) on debt extinguishment 0 920,673
Interest expense, net (12,357) (7,873)
Total Other Income (Expenses) (12,357) 912,800
Income (Loss) before Provision for Income Taxes (517,828) 82,504
Income Taxes Provision (Benefit) 0 (235)
Net Income (Loss) $ (517,828) $ 82,739
Net Income (Loss) per Common Share:    
Basic – Net Income (Loss) Attributable to Common Stockholders $ (0.00) $ 0.00
Diluted – Net Income (Loss) Attributable to Common Stockholders $ (0.00) $ 0.00
Weighted Average Common Shares Outstanding used in Computing Basic Net Income/Loss Per Share 286,542,208 136,311,335
Weighted Average Common Shares Outstanding used in Computing Diluted Net Income/Loss Per Share 286,542,208 136,311,335
Product [Member]    
Total Net Revenue $ 1,954,430 $ 1,107,864
Total Cost of Sales 1,132,900 577,814
Recurring [Member]    
Total Net Revenue 196,275 186,345
Total Cost of Sales $ 31,770 $ 10,900